![]() |
|
|
Food and Biodynamic Chemistry Laboratory, Graduate School of Life Science and Agriculture, Tohoku University, Sendai, 981-8555, Japan
1To whom correspondence should be addressed. E-mail: miyazawa{at}biochem.tohoku.ac.jp.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: conjugated linoleic acid conjugated eicosapentaenoic acid nude mice lipid peroxidation conjugated fatty acid
Fatty acids with conjugated double bonds exist in nature, but occur only in small quantities. A conjugated linoleic acid (CLA; 18:2),2 a geometrical and positional isomer of linoleic acid (LA; 9Z12Z-18:2), is found in dairy products such as milk and cheese; its basic component is 9Z11E-CLA (1) (Fig. 1). The seeds of some plants include conjugated triene fatty acids such as
-eleostearic acid (9Z11E13E-18:3) and calendic acid (8E10E12Z-18:3), and tetraene fatty acids such as parinaric acid (9Z11E13E15Z-18:4) (2,3); seaweeds such as red and green algae contain more highly unsaturated conjugated fatty acids, i.e., conjugated EPA (CEPA; 5Z7E9E14Z17Z-20:5) (Fig. 1), bosseopentaenoic acid (5Z8Z10E12ZE14Z-20:5) and stellaheptaenoic acid (4Z7Z9E11E13Z16Z19Z-22:7) (4,5).
|
-linolenic acid, EPA, and DHA induced a strong and selective apoptosis in cultured human tumor cells, with the mechanism proceeding via lipid peroxidation (10,11). To verify the in vivo antitumor effect of CEPA, the fatty acid that was most effective in cultured cell lines, in this study, we transplanted DLD-1 human colon tumor cells into nude mice, and fed the mice CEPA, CLA, or EPA. We then compared the tumor cell growth among the CEPA-, CLA- and EPA-fed mice and investigated the mechanism of the antitumor activity.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Preparation of safflower oil fatty acids and CEPA. Safflower oil fatty acid was prepared from safflower oil by saponification using a previously reported method (11). In our previous study, CEPA, which has a conjugated trienoic structure, had the strongest cytotoxic effect (10); in the current study, CEPA was prepared from EPA by alkaline isomerization using the same method as that previously reported (11,12). Potassium hydroxide at a concentration of 21 g/100 g in ethylene glycol was prepared, and nitrogen gas was bubbled through the solution for 10 min. EPA (100 mg) was added to 10 mL of the 4 mol/L KOH solution in a test tube (100 mL volume). Nitrogen gas was again bubbled through the mixture, and then the tube was screw-capped and allowed to stand for 10 min at 180°C. The reaction mixture was cooled, 10 mL of methanol was added, and then the mixture was acidified to below pH 2.0 with 20 mL of 6 mol/L HCl. After dilution with 2 mL of distilled water, the conjugated fatty acids were extracted with 5 mL of hexane. The hexane extract was then washed with 3 mL of 30% methanol and 3 mL of distilled water before evaporation under a nitrogen gas stream. The CEPA concentrate was stored at 20°C after being purged with nitrogen gas. UV/VIS spectrophotometric analysis of the conjugated fatty acid was performed with a Shimadzu UV-2400PC, and confirmed the presence of conjugated fatty acids containing dienes (absorption at 235 nm), trienes (268 nm), tetraenes (315 nm), pentaenes (345 nm), and hexaenes (375 nm) (13). The CEPA oil used in the subsequent experiments consisted of 57.6% conjugated dienes, 34.5% conjugated trienes, 7.7% conjugated tetraenes, and 1.2% conjugated pentaenes. The CEPA diet contained 20 g/100 g of total fatty acids as CEPA, and was fed to the mice for 4 wk.
Cells and cell cultures. The human colon tumor cell line (DLD-1) was obtained from the Cell Resource Center for Biochemical Research at Tohoku University. The cell line was cultured in RPMI 1640 medium (containing 0.3 g/L L-glutamine and 2.0 g/L sodium bicarbonate) supplemented with 10% FBS, 100 kU/L penicillin, and 100 mg/L streptomycin. The DLD-1 cells were maintained at 37°C in a humidified atmosphere of 95% air and 5% CO2.
Animals and treatments.
Male athymic nude mice (BALB/cA Jcl-nu nu/nu, 4 wk old) were obtained from Japan Clea and maintained in a clean environment. A commercial diet (CL-2)3 for the mice was purchased from Japan Clea. This is a vitamin-enriched feed that is used in the breeding of germ-free animals and immunodeficient animal models such as nude mice. After acclimatization for 1 wk, tumor cells (DLD-1) were subcutaneously inoculated into the nude mice. DLD-1 cells in culture were detached by trypsinization and washed with PBS. Cell suspensions of 5 x 106 cells in 100 mL of PBS were injected into the back region of each nude mouse using an 18-gauge needle. Mice were randomly divided into 4 groups 2 d after tumor cell inoculation; this day was considered to be the initial test day. The 4 groups were defined by the dietary test oils fed to the mice, as follows: the control group (n = 10), the CLA group (n = 10), the EPA group (n = 10), and the CEPA group (n = 10). The CLA oil, EPA oil, and CEPA oil contained CLA, EPA, and CEPA, respectively, as 20 g/100 g of the total fatty acid concentration. The test oil (50 mg) was administered orally to each mouse once every 2 d for 4 wk. Body weight and tumor size were measured once every 2 d after tumor cell inoculation. The tumor weight was estimated by the following formula (14):
![]() |
The body weight of the host alone was estimated by the following formula (14):
![]() |
The mice were caged individually, given free access to food and distilled water, and housed in a temperature- and humidity-controlled room with a 12-h light:dark cycle. All procedures were performed in accordance with the Animal Experiment Regulations of Tohoku University. After the 4-wk experimental feeding period, the mice were killed by decapitation and blood was collected into a EDTA-treated blood collection tubes. Plasma was prepared from the blood by centrifugation at 1000 x g for 15 min at 4°C, and was then stored at 80°C until analysis. Immediately after blood collection, all tumor and liver tissues were perfused in situ with ice-cold saline, removed, and stored at 80°C until assayed. After defrosting, DNA fragmentation in the tumor tissue was evaluated to confirm apoptosis in the tumor cells, and a DNA ladder assay was also performed (see below). Membrane phospholipid hydroperoxides and TBARS were also measured in the defrosted plasma, liver, and tumor tissues to confirm the occurrence of lipid peroxidation in vivo.
GC analysis. Test oils with a known amount of heptadecanoic acid (17:0; Sigma) as an internal standard were treated with 4% HCl:methanol (v:v) for 20 min at 60°C to prepare the FAME. These were then subjected to GC (GC 353B, GL Sciences) with a flame-ionization detector and a Supelcowax-10 fused silica capillary column (60 m x 0.32 mm i.d., Supelco). The GC conditions were programmed as described previously (15). The respective test oils contained CLA, EPA, and CEPA as 20 g/100 g of the total fatty acids (Table 1). The test oils were prepared as follows: the control oil was prepared with safflower oil fatty acids (safflower oil fatty acids = 100%), the CLA oil with safflower oil fatty acids and CLA (safflower oil fatty acids:CLA = 75:25, v:v), the EPA oil with safflower oil fatty acids and EPA (safflower oil fatty acids:EPA = 78:22, v:v), and the CEPA oil with safflower oil fatty acids and CEPA (safflower oil fatty acids:CEPA = 78:22, v:v).
|
DNA fragmentation assay. The outer part of the solid tumor was transferred into a glass tube, suspended in lysis buffer (5 mmol/L Tris, 20 mmol/L EDTA, 0.5% Triton X-100, pH 8.0), and incubated for 30 min at 4°C. After incubation, the tube was centrifuged at 15000 x g for 20 min to separate the intact chromatin from the DNA fragments. After centrifugation, 1 mL of lysis buffer was added to the pellets. Both the pellets and supernatants were assayed for DNA concentration using diphenylamine (16). The results were expressed as the ratio of DNA concentration in the supernatant to the total DNA concentration recovered in both the pellet and the supernatant.
Determination of phospholipid hydroperoxides. Membranous phospholipid hydroperoxides, i.e., phosphatidylcholine hydroperoxide (PCOOH) and phosphatidylethanolamine hydroperoxide (PEOOH), in tumor tissues, liver, and plasma were determined by a chemiluminescence detection-HPLC (CL-HPLC) method, as described by Miyazawa et al. (1719). The CL-HPLC system consisted of a Jasco HPLC system (Japan Spectroscopic) combined with a CLD-100 chemiluminescence detector (Tohoku Electronic Industries) and a Jasco UV detector (UV-970) equipped with a Jasco Finepak SIL NH25 column (n-propylamine-bound silica column, 5-µm particle size, 250 x 4.6 mm). The mobile phase consisted of 2-propanol:methanol:water (1350:450:200, by vol), and the flow rate was 1.0 mL/min. The luminescent reagent was prepared by dissolving cytochrome c (from horse heart, type 4; Sigma) and luminol (3-aminophytaloyl hydrazine; Wako Pure Chemical) in an alkaline borate buffer (pH 10) and was added at a flow rate of 1.2 mL/min. Tumor and liver tissues were homogenized with 4 volume equivalents of ice-cold saline. The total lipids of the plasma and the tissue homogenates were extracted by Folchs procedure (20), and the total lipid extracts from the tumor tissue, liver tissue, and plasma were used as samples. A calibration curve was made for PCOOH prepared by photooxidation of synthetic phosphatidylcholine (1-hexadecanoyl-2-[9-cis-octadecadienoyl]-sn-glycero-3-phosphocholine, Sigma).
TBARS assay. Tumor tissues, liver tissues, and plasma were assayed for TBARS as a conventional index for lipid peroxidation (21,22). Tumor and liver tissues were homogenized with 4 volume equivalents of ice-cold saline. Plasma (20 µL) and 20% tissue homogenate samples (20 µL) were transferred to a glass tube, and 4.5 mL of a 0.67% TBA solution was added. Then the tubes were screw-capped and centrifuged at 3000 x g for 5 min. Next, 1.5 mL of the supernatant was transferred to another tube and centrifuged at 15000 x g for 5 min at 4°C. The supernatant fluorescence was measured at 553 nm with excitation at 515 nm in a Jasco FP-750. Fluorescence intensity was converted to nmol of malondialdehyde equivalents based on a standard curve generated with 1,1,3,3-tetraethoxypropane.
Statistical analysis. Statistical analysis was performed using one-way ANOVA, followed by a Newman-Keuls test for multiple comparisons among several groups. A difference was considered significant at P < 0.05.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The CLA and CEPA oils that were fed to the mice contained a large number of isomers, because these fatty acids were prepared by alkaline isomerization. The main natural form of CLA is 9Z11E-CLA (Fig. 1) (1), but CLA prepared by alkaline isomerization contains 2 major components, i.e., 9Z11E-CLA and 10E12Z-CLA; it was confirmed that the former has little antitumor effect, whereas the latter has a strong effect (23). GC analysis showed that the CLA used in this study consisted of 44.8% 9Z11E-CLA, 46.2% 10E12Z-CLA, 3.6% all-Z-CLA, and 5.4% all-E-CLA. The difference in activity among the isomers was not compared, but it is likely that a significant effect on tumor growth would have been found, compared with the control group, if the CLA consisted only of the 10E12Z-CLA isomer, which is considered to have strong activity. CEPA isomers such as 5Z7E9E14Z17Z-20:5 and 5E7E9E14Z17Z-20:5 are found in nature in red algae (Fig. 1) (4), but the amounts of these molecules are extremely small, and it is very difficult to extract and purify CEPA from red algae. CEPA prepared by alkaline isomerization contains more isomers than similarly prepared CLA; at present, it is difficult to identify all of the CEPA isomers. As shown for CLA, it is possible that some CEPA isomers produced by alkaline isomerization have little antitumor effect; therefore, the bioactivity of each isomer should be investigated.
The results of this study indicated that compared with EPA and CLA, CEPA had an extremely strong antitumor effect on tumor cells that were transplanted into nude mice (Fig. 2). Antitumor mechanisms of fatty acids were reported to include lipid peroxidation, modulated eicosanoid production due to changes in component fatty acids, and changes in membrane fluidity (9). There are also reports that the lipid peroxide itself can induce apoptosis and inhibition of cell growth (2429). In the tumor cells of mice that were fed CEPA, the membrane phospholipid hydroperoxide and TBARS levels were increased (Tables 2, and 3), suggesting that apoptosis was induced via lipid peroxidation as we showed previously in cell culture (10).
CEPA had no effect on normal liver tissues or on plasma (Fig. 3, Tables 2, and 3). We reported previously that in rats fed
-eleostearic acid (9Z11E13E-18:3), a conjugated fatty acid purified from plant seed, as 1% of the total feed weight for 4 wk, no significant differences were found in the lipid components of the plasma and liver, and no change in oxidative stress occurred, compared with groups fed linoleic acid,
-linolenic acid, and CLA (30). These results suggest that conjugated fatty acids have little or no effect on normal tissues, even at a concentration at which they affect tumor cells. Hence, we concluded that the tumor cells were less resistant to oxidative stress than normal cells. Administration of an unsaturated fatty acid such as CEPA, which is subject to lipid peroxidation, creates oxidative stress in tumor cells, but not in normal tissue (Tables 2, and 3). The lack of CEPA effects on normal tissue could be very desirable for food applications.
It is difficult to separate the CLA isomers prepared by alkaline isomerization in bulk. Therefore, to test the safety of administration of CLA to humans, the CLA isomer mixture was examined in long-term safety studies and clinical trials in humans. At present, CLA prepared by alkaline isomerization is on the market as a health supplement. Here, we showed that a similar preparation of CEPA, an (n-3) highly unsaturated fatty acid with conjugated double bonds, had a stronger in vivo antitumor effect than EPA and CLA, and that the antitumor mechanism occurred through lipid peroxidationinduced apoptosis. Hence, the use of CEPA in food and medicine is likely to have great promise after its safety is confirmed in long-term safety studies and clinical trials similar to those performed for CLA. Further studies of CEPA are warranted to verify the effectiveness of long-term administration and to investigate the specific active form of CEPA.
| FOOTNOTES |
|---|
3 Approximate composition of CL-2 (g/kg diet): carbohydrate, 477; protein, 240; fat, 55; fiber, 46; moisture, 90; ash, 92. ![]()
Manuscript received 29 October 2003. Initial review completed 13 December 2003. Revision accepted 23 February 2004.
| LITERATURE CITED |
|---|
|
|
|---|
1. Ha, Y. L., Grimm, N. K. & Pariza, M. W. (1987) Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 8:1881-1887.
2. Hopkins, Y. (1972) Fatty acids with conjugated unsaturation. Gunstone, F. D. eds. Topics in Lipid Chemistry 1972:37-87 ELEK Science London, UK. .
3. Badami, R. C. & Patil, K. B. (1981) Structure and occurrence of unusual fatty acids in minor seed oils. Prog. Lipid Res. 19:119-153.
4. Lopez, A. & Gerwick, W. H. (1987) Two new icosapentaeinoic acids from the temperate red seaweed Ptilota filicina J. Agardh. Lipids 22:190-194.
5. Mikhailova, M. V., Bemis, D. L., Wise, M. L., Gerwick, W. H., Norris, J. N. & Jacobs, R. S. (1995) Structure and biosynthesis of novel conjugated polyene fatty acids from the marine green alga Anadyomene stellate. Lipids 30:583-589.[Medline]
6. Lee, K. N., Kritchevsky, D. & Pariza, M. W. (1994) Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108:19-25.[Medline]
7. Park, Y., Albright, K. J., Storkson, J. M., Liu, W., Cook, M. E. & Pariza, M. W. (1999) Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 34:243-248.[Medline]
8. Ip, C., Chin, S. F., Scimeca, J. A. & Pariza, M. W. (1991) Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res. 51:6118-6124.
9. Cave, W. T., Jr (1991) Dietary n-3 (
-3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J. 5:2160-2166.[Abstract]
10. Igarashi, M. & Miyazawa, T. (2000) Do conjugated eicosapentaenoic acid and conjugated docosahexaenoic acid induce apoptosis via lipid peroxidation in cultured human tumor cells?. Biochem. Biophys. Res. Commun. 270:649-656.[Medline]
11. Igarashi, M. & Miyazawa, T. (2000) Newly recognized cytotoxic effect of conjugated trienoic fatty acids on cultured human tumor cells. Cancer Lett. 148:173-179.[Medline]
12. Helrich, K. (1990) Acids (polyunsaturated) in oil and fats. Official Methods of Analysis 1990:960-963 Association of Official Analytical Chemists Arlington, VA.
13. Pitt, G.A.J. & Morton, R. A. (1957) Ultra-violet spectrophotometry of fatty acids. Prog. Chem. Fats Other Lipids 4:227-278.
14. Kitagawa, Y., Ueda, M., Ando, N., Ozawa, S. & Kitajima, M. (1995) Effect of endogenous and exogenous EGF on the growth of EGF receptor-hyperproducing human squamous cell carcinoma implanted in nude mice. Br. J. Cancer 72:865-868.[Medline]
15. Igarashi, M. & Miyazawa, T. (2001) The growth inhibitory effect of conjugated linoleic acid on a human hepatoma cell line, HepG2, is induced by a change in fatty acid metabolism, but not the facilitation of lipid peroxidation in the cells. Biochim. Biophys. Acta 1530:162-171.[Medline]
16. Burton, K. (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62:315-323.[Medline]
17. Miyazawa, T., Fujimoto, K., Suzuki, T. & Yasuda, K. (1994) Determination of phospholipid hydroperoxides using luminol chemiluminescence-high-performance liquid chromatography. Methods Enzymol. 233:324-332.[Medline]
18. Miyazawa, T., Suzuki, T., Fujimoto, K. & Yasuda, K. (1992) Chemiluminescent simultaneous determination of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide in the liver and brain of the rat. J. Lipid Res. 33:1051-1059.[Abstract]
19. Song, J. H., Fujimoto, K. & Miyazawa, T. (2000) Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils. J. Nutr. 130:3028-3033.
20. Folch, J., Lees, M. & Sloane Stanley, G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
21. Gavino, V. C., Miller, J. S., Ikharebha, S. O., Milo, G. E. & Cornwell, D. G. (1981) Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J. Lipid Res. 22:763-769.[Abstract]
22. Song, J. H. & Miyazawa, T. (2001) Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oils. Atherosclerosis 155:9-18.[Medline]
23. Miller, A., Stanton, R. & Devery, C. (2002) Cis 9, trans 11- and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Res. 22:3879-3887.[Medline]
24. Esterbauer, H. (1993) Cytotoxicity and genotoxicity of lipid oxidation products. Am. J. Clin. Nutr. 57:779S-786S.
25. Grune, T., Siems, W. G., Zollner, H. & Esterbauer, H. (1994) Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages. Cancer Res. 54:5231-5235.
26. Sandstrom, P. A., Tebbey, P. W., Van Cleave, S. & Buttke, T. M. (1994) Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. J. Biol. Chem. 269:798-801.
27. Sandstrom, P. A., Pardi, D., Tebbey, P. W., Dudek, R. W., Terrian, D. M., Folks, T. M. & Buttke, T. M. (1995) Lipid hydroperoxide-induced apoptosis: lack of inhibition by Bcl-2 over-expression. FEBS Lett. 365:66-70.[Medline]
28. Aoshima, H., Satoh, T., Sakai, N., Yamada, M., Enokiko, Y., Ikeuchi, T. & Hatanaka, H. (1997) Generation of free radicals during lipid hydroperoxide-triggered apoptosis in PC12h cells, Biochim. Biophys. Acta 1345:35-42.[Medline]
29. Ji, C., Rouzer, C. A., Marnett, L. J. & Pietenpol, J. A. (1998) Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis 19:1275-1283.
30. Tsuzuki, T., Igarashi, M., Komai, M. & Miyazawa, T. (2003) A metabolic conversion of 9, 11, 13-eleostearic acid (18:3) to 9, 11-conjugated linoleic acid (18:2) in the rat. J. Nutr. Sci. Vitaminol. 49:195-200.
This article has been cited by other articles:
![]() |
T. Tsuzuki and Y. Kawakami Tumor angiogenesis suppression by {alpha}-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via peroxisome proliferator-activated receptor {gamma} Carcinogenesis, April 1, 2008; 29(4): 797 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuzuki, A. Shibata, Y. Kawakami, K. Nakagawa, and T. Miyazawa Conjugated Eicosapentaenoic Acid Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Migration of Human Umbilical Vein Endothelial Cells J. Nutr., March 1, 2007; 137(3): 641 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuzuki, Y. Kawakami, R. Abe, K. Nakagawa, K. Koba, J. Imamura, T. Iwata, I. Ikeda, and T. Miyazawa Conjugated Linolenic Acid Is Slowly Absorbed in Rat Intestine, but Quickly Converted to Conjugated Linoleic Acid J. Nutr., August 1, 2006; 136(8): 2153 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuzuki, Y. Tokuyama, M. Igarashi, K. Nakagawa, Y. Ohsaki, M. Komai, and T. Miyazawa {alpha}-Eleostearic Acid (9Z11E13E-18:3) Is Quickly Converted to Conjugated Linoleic Acid (9Z11E-18:2) in Rats J. Nutr., October 1, 2004; 134(10): 2634 - 2639. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||